Lawood & Co’s Pfizer PFE Stock Holding History

Lawood & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$357K	Sell	14,818 -733	-5%	-$19.2K	0.24%	71
2026 Q1	$437K	Sell	15,551 -356	-2%	-$9.48K	0.41%	60
2025 Q4	$396K	Buy	+15,907	New	+$401K	0.38%	65

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Lawood & Co's PFE Position: Q2 2026 in Review

Lawood & Co reduced its Pfizer (PFE) stake by 4.7% in Q2 2026, selling an estimated $19.2K and leaving 14,818 shares worth $357K. The position accounts for 0.24% of the portfolio, ranked #71.

Lawood & Co first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $437K in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Lawood & Co held 14,818 shares of Pfizer worth $357K as of Q2 2026.
Lawood & Co sold 733 Pfizer shares in Q2 2026, an estimated $19.2K.
Pfizer made up 0.24% of Lawood & Co's portfolio in Q2 2026, its #71 holding.
Lawood & Co first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
Lawood & Co's Pfizer position peaked at $437K in Q1 2026.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Lawood & Co's 13F filing for Q2 2026, filed 13 Jul 2026.